Difference between revisions of "Team:TCU Taiwan/Project/Our Design"
Line 107: | Line 107: | ||
</tr> | </tr> | ||
</table> | </table> | ||
− | |||
</p> | </p> | ||
Revision as of 11:01, 7 September 2015
Antimicrobial peptide |
Antibiotic administration is the current method of choice to fight a bacterial infection. However, due to over-use of antibiotics, drug-resistant bacteria have emerged and frequently appear. This complication makes decreases wound healing potential and makes recovery increasingly difficult. Currently, more focus has been placed on new anti-infectious agents to fight these drug-resistant pathogens.
|
Reference
[1] | Yeaman, M.R. and N.Y. Yount, Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev, 2003. 55(1): p. 27-55. |
[2] | Lai, Y. and R.L. Gallo, AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol, 2009. 30(3): p. 131-41. |
[3] | TU_Delf, i.t. 2013; Available from: https://2013.igem.org/Team:TU-Delft. |
[4] | Huang, H.N., et al., Use of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuries. Biomaterials, 2013. 34(38): p. 10319-27. |
Contact us tcutaiwan@gmail.com No.701, Sec. 3, Zhongyang Rd. Hualien 97004, Taiwan |